Aptevo Therapeutics Inc (APVO)

08:44 AM

Aptevo Therapeutics Inc (APVO) Shares Are Down -85.25% YTD - Marketing Sentinel

08:44 AM

08:15 AM

SEC Form 424B4 filed by Aptevo Therapeutics Inc. - Quantisnow

08:15 AM

Apr 21, 2025

Aptevo Therapeutics announces $2 million stock offering By Investing.com - Investing.com South Africa

Apr 21, 2025

Apr 21, 2025

Aptevo Therapeutics (APVO) Secures $2M Through Registered Direct Offering | APVO Stock News - GuruFocus

Apr 21, 2025

Apr 21, 2025

Aptevo Therapeutics $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | APVO Stock News - GuruFocus

Apr 21, 2025

Apr 21, 2025

Aptevo Therapeutics announces $2 million stock offering - Investing.com

Apr 21, 2025

Apr 21, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 21, 2025

Apr 21, 2025

Aptevo Therapeutics Raises Fresh Capital: $2M Boost for Revolutionary Cancer Treatment Development - Stock Titan

Apr 21, 2025

Apr 21, 2025

Aptevo Therapeutics Inc (APVO) Stock: Navigating a Year of Volatility - investchronicle.com

Apr 21, 2025

Apr 21, 2025

How does APVO’s price to cash per share ratio compare in the market? - uspostnews.com

Apr 21, 2025

Apr 21, 2025

Aptevo Therapeutics (APVO) Completes $2.1 Million Stock Offering - GuruFocus

Apr 21, 2025

Apr 21, 2025

Why Netflix Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga

Apr 21, 2025

Apr 15, 2025

APVO stock plunges to 52-week low, touches $0.94 By Investing.com - Investing.com South Africa

Apr 15, 2025

Apr 15, 2025

APVO stock plunges to 52-week low, touches $0.94 - Investing.com Australia

Apr 15, 2025

Apr 10, 2025

Alligator Bioscience and Aptevo Therapeutics to Present Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types at ESMO Congress 2024 - ACCESS Newswire

Apr 10, 2025

Apr 06, 2025

Aptevo Stock Rises On $2.1M Registered Direct Offering, Warrant Sale: Retail Sentiment Touches Year-High - Asianet Newsable

Apr 06, 2025

Apr 04, 2025

Aptevo Therapeutics Announces the Closing of $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules - ACCESS Newswire

Apr 04, 2025

Apr 04, 2025

Aptevo Secures Fresh $2.1M Capital: What This Means for Clinical Pipeline - Stock Titan

Apr 04, 2025

Apr 03, 2025

Strategic Moves Drive Stock Gains For OSR, Lianhe Sowell, And Aptevo - Finimize

Apr 03, 2025

Apr 03, 2025

Aptevo (APVO) Sees Significant Market Rally After Equity Offering - Stocks Telegraph

Apr 03, 2025

Apr 03, 2025

11 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Apr 03, 2025

Apr 03, 2025

Aptevo Therapeutics Launches $2.1 Million Registered Direct Offering; Shares Rise - MarketScreener

Apr 03, 2025

Apr 03, 2025

Aptevo Therapeutics (APVO) Announces $2.1 Million Securities Off - GuruFocus

Apr 03, 2025

Apr 03, 2025

Aptevo Therapeutics announces registered direct offering and warrants sale - Investing.com

Apr 03, 2025

Apr 03, 2025

Aptevo Therapeutics prices 1.76M shares at $1.19 in registered direct offering - TipRanks

Apr 03, 2025

Apr 03, 2025

Aptevo Raises Fresh Capital: $2.1M Direct Offering Plus Warrant Restructuring - Stock Titan

Apr 03, 2025

Apr 03, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Apr 03, 2025

Apr 03, 2025

Why Penguin Solutions Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga

Apr 03, 2025

Apr 02, 2025

Aptevo Therapeutics Announces 1-for 44 Reverse Stock Split As Part of Nasdaq Compliance Plan - ACCESS Newswire

Apr 02, 2025

Apr 02, 2025

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Apr 02, 2025

Apr 01, 2025

APVO stock plunges to 52-week low, touches $0.99 By Investing.com - Investing.com India

Apr 01, 2025

Apr 01, 2025

APVO stock plunges to 52-week low, touches $0.99 - Investing.com

Apr 01, 2025

Mar 31, 2025

Virtu Financial LLC Has $93,000 Stake in Aptevo Therapeutics Inc. (NASDAQ:APVO) - Defense World

Mar 31, 2025

Mar 30, 2025

Aptevo Therapeutics Inc. (NASDAQ:APVO) Sees Significant Growth in Short Interest - Defense World

Mar 30, 2025

Mar 25, 2025

APVO stock plunges to 52-week low, touches $2.32 - Investing.com India

Mar 25, 2025

Mar 24, 2025

APVO stock plunges to 52-week low, touches $2.32 By Investing.com - Investing.com UK

Mar 24, 2025

Mar 20, 2025

Aptevo Therapeutics Says Two Additional Patients In Early-Stage Leukemia Trial Achieve Remission Within 30 Days of Treatment - Benzinga

Mar 20, 2025

Mar 20, 2025

Aptevo Therapeutics Reports 2 More Remissions in AML Trial -March 20, 2025 at 09:35 am EDT - Marketscreener.com

Mar 20, 2025

Mar 20, 2025

Aptevo Therapeutics Achieves Remission Success in AML Trial - TipRanks

Mar 20, 2025

Mar 20, 2025

Aptevo reports two additional AML patients achieve remission in RAINIER trial - TipRanks

Mar 20, 2025

Mar 20, 2025

Breakthrough: New AML Drug Shows 90% Success Rate, Outperforming Standard Therapy by 24% - StockTitan

Mar 20, 2025

Mar 18, 2025

Aptevo Therapeutics advances cancer antibody APVO603 in preclinical phase - Investing.com

Mar 18, 2025

Mar 18, 2025

Aptevo Highlights APVO603: A Novel Bispecific Antibody Targeting 4-1BB and OX40 for Enhanced Solid Tumor Immunotherapy - ACCESS Newswire

Mar 18, 2025

Mar 18, 2025

Breakthrough Cancer Drug APVO603 Targets Two Immune Pathways to Fight Solid Tumors - Stock Titan

Mar 18, 2025